GlassScriptPhysician profile
Suzan E Zimmer
NPI 1750351151
$2,809.65
in general payments reported to CMS, 2019-2025
34 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $368 · 2021: $323 · 2022: $811 · 2023: $385 · 2024: $236 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $477.76 | 2019-2025 | Breztri, Farxiga |
| Pfizer INC. | $350.86 | 2019-2025 | |
| Novo Nordisk INC | $285.31 | 2019-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.67 | 2019-2023 | Xifaxan |
| Abbvie INC. | $168.25 | 2022-2025 | Ubrelvy, Vraylar |
| Glaxosmithkline, LLC. | $165.25 | 2020-2025 | Trelegy Ellipta |
| Sunovion Pharmaceuticals INC. | $161.17 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $124.84 | 2021-2023 | |
| Lilly USA, LLC | $122.06 | 2019-2025 | Mounjaro, Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.06 | 2022-2025 | Caplyta |
| Exact Sciences Corporation | $72.91 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $65.59 | 2020-2023 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $62.08 | 2022-2023 | |
| Abbott Laboratories | $57.06 | 2022-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $40.44 | 2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $37.92 | 2022 | |
| Hologic Sales and Service, LLC | $37.25 | 2020 | |
| Almatica Pharma LLC | $32.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.45 | 2023 | Xarelto |
| Ibsa Pharma INC. | $21.64 | 2022 | |
| Melinta Therapeutics, LLC | $21.58 | 2019 | |
| Radius Health, INC. | $20.62 | 2022 | |
| Xeris Pharmaceuticals, INC. | $20.36 | 2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $19.51 | 2022 | |
| Astellas Pharma US INC | $19.34 | 2023 | Veozah |
| Arbor Pharmaceuticals, INC. | $19.26 | 2019 | |
| Lundbeck LLC | $18.82 | 2025 | Rexulti |
| Sonex Health, INC. | $17.42 | 2025 | Sx-One Microknife |
| Eisai INC. | $16.37 | 2020 | |
| Organon LLC | $15.61 | 2022 | |
| Esperion Therapeutics, INC. | $15.31 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.20 | 2019 | |
| Gilead Sciences, INC. | $13.99 | 2020 | |
| Philips North America LLC | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzan Zimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.